USFDA conducts pre-approval inspection at Lupin’s Somerset facility

11 Oct 2025 Evaluate

United States Food and Drug Administration (USFDA) has conducted a Pre-Approval Inspection at Lupin’s manufacturing facility located in Somerset, New Jersey, U.S.A. The Inspection was conducted from September 29, 2025 to October 10, 2025, and concluded with one observation. The company will address the observation and respond to the USFDA within the stipulated timeframe. It is committed to be compliant with CGMP standards across all its facilities.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2165.05 25.65 (1.20%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×